These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28011910)

  • 41. Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
    Morrison BJ; Roman JA; Luke TC; Nagabhushana N; Raviprakash K; Williams M; Sun P
    J Virol Methods; 2017 Oct; 248():7-18. PubMed ID: 28624584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affect NA Enzyme Activity, Hemagglutination Titer, Mouse Virulence, and Inactivated-Virus Immunogenicity.
    Chen TH; Chen CC; Wu SC
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.
    Vanderven HA; Jegaskanda S; Wines BD; Hogarth PM; Carmuglia S; Rockman S; Chung AW; Kent SJ
    J Infect Dis; 2017 Dec; 217(1):12-23. PubMed ID: 29106590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.
    Huang B; Wang W; Li R; Wang X; Jiang T; Qi X; Gao Y; Tan W; Ruan L
    Virol J; 2012 Dec; 9():322. PubMed ID: 23272943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection.
    Fujimoto Y; Tomioka Y; Takakuwa H; Uechi GI; Yabuta T; Ozaki K; Suyama H; Yamamoto S; Morimatsu M; Mai LQ; Yamashiro T; Ito T; Otsuki K; Ono E
    J Gen Virol; 2016 Sep; 97(9):2104-2116. PubMed ID: 27260213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.
    Jegaskanda S; Weinfurter JT; Friedrich TC; Kent SJ
    J Virol; 2013 May; 87(10):5512-22. PubMed ID: 23468501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
    Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.
    Florek K; Mutschler J; McLean HQ; King JP; Flannery B; Belongia EA; Friedrich TC
    Vaccine; 2020 Feb; 38(8):2088-2094. PubMed ID: 31753674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of mouse monoclonal antibody for detecting hemagglutinin of avian influenza A(H7N9) virus and preventing virus infection.
    Chiang YW; Li CJ; Su HY; Hsieh KT; Weng CW; Chen HW; Chang SC
    Appl Microbiol Biotechnol; 2021 Apr; 105(8):3235-3248. PubMed ID: 33770244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus.
    LaMere MW; Lam HT; Moquin A; Haynes L; Lund FE; Randall TD; Kaminski DA
    J Immunol; 2011 Apr; 186(7):4331-9. PubMed ID: 21357542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs.
    Gromadzka B; Chraniuk M; Hovhannisyan L; Uranowska K; Szewczyk B; Narajczyk M; Panasiuk M
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-neutralizing Anti-hemagglutinin Antibodies Isolated from Patients Infected with Avian Influenza A (H5N1) Virus.
    Sun Y; Cao Y; Li Z; Bai T; Zhang H; Hu SX; Li FC; Zhao X; Chen YK; Lu J; Liu LQ; Wang DY; Shu YL; Zhou JF
    Biomed Environ Sci; 2020 Feb; 33(2):103-113. PubMed ID: 32131957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases.
    Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Okuda M; Kawaoka Y
    Nat Commun; 2022 Nov; 13(1):6602. PubMed ID: 36329075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine.
    Kristensen AB; Lay WN; Ana-Sosa-Batiz F; Vanderven HA; Madhavi V; Laurie KL; Carolan L; Wines BD; Hogarth M; Wheatley AK; Kent SJ
    J Virol; 2016 Jun; 90(12):5724-5734. PubMed ID: 27053553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
    PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.
    Marcelin G; DuBois R; Rubrum A; Russell CJ; McElhaney JE; Webby RJ
    PLoS One; 2011; 6(10):e26335. PubMed ID: 22039464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.